Genomic, Epigenomic And Transcriptomic Regulation Of Cellular Senescence
Imagine cells in your body that, instead of dividing, decide to retire. This state, called cellular senescence, happens when cells experience stress or damage. While these ‘retired’ cells stop multiplying, they don’t just sit idly; they undergo significant changes and can influence their surroundings. Scientists are discovering that this process is incredibly complex, governed by how a cell’s entire genetic blueprint (its genome) is organized, how genes are switched on or off without changing the DNA sequence itself (epigenomics), and which genes are actively producing instructions (transcriptomics).
For instance, the way DNA is packaged within a cell, a process known as chromatin remodeling, changes dramatically in senescent cells, affecting which genes are accessible. Chemical tags on the proteins that DNA wraps around (histone modifications) and direct chemical marks on the DNA itself (DNA methylation) also play crucial roles in determining a cell’s senescent fate and its behavior. These changes can lead to the production of a unique set of signaling molecules, collectively known as the senescence-associated secretory phenotype (SASP), which can impact nearby healthy cells and contribute to various conditions, including aging and diseases like cancer.
New technologies, such as those that analyze multiple layers of a cell’s biology simultaneously (multi-omics platforms), are providing unprecedented insights into these ‘retired’ cells. Understanding these intricate regulatory mechanisms is key to developing strategies that could potentially target senescent cells for therapeutic benefits, helping us to better manage age-related diseases and improve health.
Source: link to paper